Literature DB >> 10550330

Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors.

F Huang1, M Buttini, T Wyss-Coray, L McConlogue, T Kodama, R E Pitas, L Mucke.   

Abstract

The class A scavenger receptor (SR) is expressed on reactive microglia surrounding cerebral amyloid plaques in Alzheimer's disease (AD). Interactions between the SR and amyloid beta peptides (Abeta) in microglial cultures elicit phagocytosis of Abeta aggregates and release of neurotoxins. To assess the role of the SR in amyloid clearance and Abeta-associated neurodegeneration in vivo, we used the platelet-derived growth factor promoter to express human amyloid protein precursors (hAPPs) in neurons of transgenic mice. With increasing age, hAPP mice develop AD-like amyloid plaques. We bred heterozygous hAPP (hAPP(+/-)) mice that were wild type for SR (SR(+/+)) with SR knockout (SR(-/-)) mice. Crosses among the resulting hAPP(+/-)SR(+/-) offspring yielded hAPP(+/-) and hAPP(-/-) littermates that were SR(+/+) or SR(-/-). These second-generation mice were analyzed at 6 and 12 months of age for extent of cerebral amyloid deposition and loss of synaptophysin-immunoreactive presynaptic terminals. hAPP(-/-)SR(-/-) mice showed no lack of SR expression, plaque formation, or synaptic degeneration, indicating that lack of SR expression does not result in significant accumulation of endogenous amyloidogenic or neurotoxic factors. In hAPP(+/-) mice, ablation of SR expression did not alter number, extent, distribution, or age-dependent accumulation of plaques; nor did it affect synaptic degeneration. Our results do not support a critical pathogenic role for microglial SR expression in neurodegenerative alterations associated with cerebral beta amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550330      PMCID: PMC1866996          DOI: 10.1016/S0002-9440(10)65489-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

2.  Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.

Authors:  E Masliah; R D Terry; M Alford; R DeTeresa; L A Hansen
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

3.  A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid.

Authors:  M Mullan; F Crawford; K Axelman; H Houlden; L Lilius; B Winblad; L Lannfelt
Journal:  Nat Genet       Date:  1992-08       Impact factor: 38.330

4.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.

Authors:  J L Goldstein; Y K Ho; S K Basu; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

Review 5.  Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors.

Authors:  M Krieger; S Acton; J Ashkenas; A Pearson; M Penman; D Resnick
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

6.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state.

Authors:  C J Pike; D Burdick; A J Walencewicz; C G Glabe; C W Cotman
Journal:  J Neurosci       Date:  1993-04       Impact factor: 6.167

7.  Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia.

Authors:  S S Zhan; K Beyreuther; H P Schmitt
Journal:  Dementia       Date:  1993 Mar-Apr

8.  Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity.

Authors:  S Rabizadeh; C M Bitler; L L Butcher; D E Bredesen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice.

Authors:  S M Toggas; E Masliah; E M Rockenstein; G F Rall; C R Abraham; L Mucke
Journal:  Nature       Date:  1994-01-13       Impact factor: 49.962

10.  Spectrum of human immunodeficiency virus-associated neocortical damage.

Authors:  E Masliah; C L Achim; N Ge; R DeTeresa; R D Terry; C A Wiley
Journal:  Ann Neurol       Date:  1992-09       Impact factor: 10.422

View more
  16 in total

Review 1.  Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale.

Authors:  N Platt; S Gordon
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 2.  Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.

Authors:  S D Yan; A Roher; A M Schmidt; D M Stern
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.

Authors:  Maria E Bamberger; Meera E Harris; Douglas R McDonald; Jens Husemann; Gary E Landreth
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

4.  Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.

Authors:  Aaron Y Lai; Joanne McLaurin
Journal:  Future Neurol       Date:  2012-03-01

5.  Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.

Authors:  Kalliopi Thanopoulou; Apostolia Fragkouli; Fotini Stylianopoulou; Spiros Georgopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-12       Impact factor: 11.205

6.  Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice.

Authors:  L Mucke; G Q Yu; L McConlogue; E M Rockenstein; C R Abraham; E Masliah
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

7.  Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer Disease.

Authors:  Brian Spencer; Rewati Potkar; Jeff Metcalf; Ivy Thrin; Anthony Adame; Edward Rockenstein; Eliezer Masliah
Journal:  J Biol Chem       Date:  2015-11-30       Impact factor: 5.157

8.  CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils.

Authors:  Indra Sethy Coraci; Jens Husemann; Joan W Berman; Christine Hulette; Jennifer H Dufour; Gabriele K Campanella; Andrew D Luster; Samuel C Silverstein; Joseph B El-Khoury
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 9.  Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.

Authors:  Ahsan Habib; Darrell Sawmiller; Jun Tan
Journal:  J Neurosci Res       Date:  2016-08-17       Impact factor: 4.164

10.  Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.

Authors:  Brian J Bacskai; Stephen T Kajdasz; Megan E McLellan; Dora Games; Peter Seubert; Dale Schenk; Bradley T Hyman
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.